Masimo Corporation
MASI
주식 순위
#2169
Masimo Corporation engages in the development, manufacture, and marketing of... Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
주가
$179.95
마지막 동기화: 2026-06-12
시가총액
$9.42B
변동 (1일)
0.00%
변동 (1년)
21.32%
국가
US
거래 Masimo Corporation (MASI)
카테고리
Healthcare
Masimo Corporation (MASI)의 매출
Apr 2026 기준 매출 TTM: $1.56B
Masimo Corporation의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $1.56B입니다. 2023년에 회사는 $2.05B의 수익을 올렸으며 이는 2022년의 $2.04B 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Masimo Corporation의 수익 기록 (2002 ~ 2026)
매년 말 매출
| 연도 | 매출 | 변화 |
|---|---|---|
| 2026 (TTM) | $1.56B | -25.59% |
| 2024 | $2.09B | 2.26% |
| 2023 | $2.05B | 0.60% |
| 2022 | $2.04B | 64.28% |
| 2021 | $1.24B | 8.35% |
| 2020 | $1.14B | 21.95% |
| 2019 | $937.84M | 9.27% |
| 2018 | $858.29M | 8.61% |
| 2017 | $790.25M | 10.85% |
| 2016 | $712.90M | 13.14% |
| 2015 | $630.11M | 7.41% |
| 2014 | $586.64M | 7.20% |
| 2013 | $547.25M | 10.95% |
| 2012 | $493.23M | 12.36% |
| 2011 | $438.99M | 8.28% |
| 2010 | $405.41M | 16.12% |
| 2009 | $349.12M | 13.69% |
| 2008 | $307.07M | 19.82% |
| 2007 | $256.29M | 14.24% |
| 2006 | $224.34M | 107.93% |
| 2005 | $107.89M | 55.56% |
| 2004 | $69.36M | 48.41% |
| 2003 | $46.73M | 20.35% |
| 2002 | $38.83M | 0.00% |
유사 기업 또는 경쟁사의 매출
| 회사 | 매출 | 매출 차이 | 국가 |
|---|---|---|---|
| $46.59B | 2,889.09% |
US
|
|
| $35.48B | 2,176.80% |
IE
|
|
| $25.84B | 1,557.81% |
US
|
|
| $21.00B | 1,247.19% |
US
|
|
| - | - |
DE
|
